Arcus Biosciences (RCUS) Payables (2017 - 2026)
Arcus Biosciences' Payables was $34 million in Q2 2026, up 17.2% from $29 million a year earlier but down 12.8% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Payables at Arcus Biosciences came in at $42 million, up 133.3% from FY2024.
- Payables shows a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
- In earlier years, Payables was $18 million in FY2024 (+5.9%), $17 million in FY2023 (-15.0%), $20 million in FY2022 (+100.0%) and $10 million in FY2021 (-36.2%).
- Quarterly Payables has moved between $10 million (Q4 2021) and $42 million (Q4 2025) over five years.
- Compared with a year earlier, Payables has increased for seven straight quarters, with growth averaging 70.5% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q3 2025 (growth of 223.1%); the worst was Q2 2023 (a decline of 45.4%).
- Per Business Quant data, RCUS's Payables in the three quarters before Q2 2026 was $39 million (Q1 2026), $42 million (Q4 2025) and $42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Arcus Biosciences | 3.00 Bn | -337.34 Mn | - | 34.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.00 Mn |
| Mar 31, 2026 | 39.00 Mn |
| Dec 31, 2025 | 42.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 29.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 17.00 Mn |
| Sep 30, 2023 | 17.00 Mn |
| Jun 30, 2023 | 12.00 Mn |
| Mar 31, 2023 | 28.00 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 10.55 Mn |
| Jun 30, 2022 | 21.98 Mn |
| Mar 31, 2022 | 18.09 Mn |
| Dec 31, 2021 | 10.00 Mn |
| Sep 30, 2021 | 13.22 Mn |
API Access
Arcus Biosciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();